Squarepoint Ops LLC Reduces Position in Forte Biosciences, Inc. $FBRXDefense World · Sep 24, 2026
argenx Completes Acquisition of Forte Biosciences, Inc.GlobeNewsWire · Aug 27, 2026
Are SUNS, VREX, CHMI, FBRX Obtaining Fair Deals for their Shareholders?GuruFocus · Aug 12, 2026
Are SUNS, VREX, CHMI, FBRX Obtaining Fair Deals for their Shareholders?PRNewsWire · Aug 12, 2026
Forte Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forte Biosciences, Inc. - FBRXGuruFocus · Aug 11, 2026
Forte Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forte Biosciences, Inc. - FBRXBusiness Wire · Aug 11, 2026Forte Biosciences, Inc. is a U.S.-based biopharmaceutical company currently in its clinical development phase. The firm's key initiative involves advancing the FB-102 program, which is designed to tackle a variety of autoimmune conditions, notably vitiligo and alopecia areata. Their main offices are situated in Dallas, Texas.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 11, 2026 | -$1.08 | -$0.97 | Beat |
| May 21, 2026 | -$1.16 | -$1.24 | Miss |
| Mar 31, 2026 | -$1.42 | -$1.45 | Miss |
| Nov 14, 2025 | -$1.04 | -$0.99 | Beat |
| Aug 14, 2025 | -$1.21 | -$0.96 | Beat |
| May 15, 2025 | -$0.89 | -$1.37 | Miss |